A detailed history of Engineers Gate Manager LP transactions in Infla Rx N.V. stock. As of the latest transaction made, Engineers Gate Manager LP holds 19,849 shares of IFRX stock, worth $43,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,849
Holding current value
$43,469
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.34 - $1.73 $26,597 - $34,338
19,849 New
19,849 $30,000
Q1 2024

May 15, 2024

BUY
$1.47 - $2.03 $18,008 - $24,869
12,251 New
12,251 $18,000
Q2 2021

Aug 16, 2021

SELL
$2.72 - $4.04 $35,414 - $52,600
-13,020 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.62 - $6.34 $47,132 - $82,546
13,020 New
13,020 $51,000
Q3 2020

Nov 16, 2020

SELL
$3.7 - $5.47 $53,724 - $79,424
-14,520 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$4.59 - $8.96 $66,646 - $130,099
14,520 New
14,520 $67,000

Others Institutions Holding IFRX

About InflaRx N.V.


  • Ticker IFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,203,800
  • Market Cap $96.8M
  • Description
  • InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...
More about IFRX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.